SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Mary Seacole Synthetic CCD

PatientMary Seacole
Date of birth1954-11-23
IdentifiersMRN HR-NI027-SYN; SSN (made up) 000-27-4483
Document date2026-11-01
AuthorAdwoa Fairweather-Kent, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Visit for headaches on waking and knee pain with a fall: very high blood pressure found, without target-organ emergency; examination, ECG, laboratory tests, home monitoring, knee osteoarthritis, falls screen, her own remedies, and geriatric medicine referral. Concerns: She wants to keep walking to see her friends without fear of falling; She wants her own knowledge as a healer, and her remedies, respected rather than dismissed; She worries about the cost of medicines and getting to appointments. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Diclofenac sodium 1% topical gel, 4 g rubbed into each painful knee up to four times a day4 g to each knee up to four times a dayTopical route2026-03-09activeS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-16activeS
Chlorthalidone 12.5 mg oral tablet, one tablet each morningOne tablet each morningOral route2026-03-16 to 2026-05-11completedS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-04-13activeS
Losartan 25 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-06-15activeS

Procedures

ProcedureDatesStatusEvidence
Twelve-lead electrocardiogram: sinus rhythm at 76 per minute; left ventricular hypertrophy by voltage criteria with no strain pattern; no ischemia or arrhythmia2026-03-09 to 2026-03-09completedS
Transthoracic echocardiography: ejection fraction 64%; mild concentric left ventricular hypertrophy; normal valves; grade 1 diastolic dysfunction; no heart failure2026-04-13 to 2026-04-13completedS
Advance care planning conversation, about 25 minutes, with her consent2026-07-13 to 2026-07-13completedS

Immunizations

DateVaccineStatusEvidence
2026-07-13Pneumococcal conjugate vaccine PCV20completedS
2026-07-13Recombinant zoster vaccine, dose 1 of 2completedS
2026-09-14Recombinant zoster vaccine, dose 2 of 2completedS
2026-09-14Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)completedS
2026-09-14Influenza vaccine, high-dosecompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1851Cholera in Cruces, Panama, by her own account, with chills and rapid onset; recoveredD (CLM-0006)
1856Returned from the Crimean War "shaken in health," tiring with little labour; no diagnosis recordedD (CLM-0009)

Family History

RelativeConditionAge at deathEvidence
motherA healer who taught her traditional Jamaican medicine; died decades ago; cause not recorded in the cited sourceD (CLM-0003, CLM-0004)

Health Concerns

ConcernStatusEvidence
She wants to keep walking to see her friends without fear of fallingactiveS
She wants her own knowledge as a healer, and her remedies, respected rather than dismissedactiveS
She worries about the cost of medicines and getting to appointmentsactiveS

Assessment

Most recent measures: Sodium [Moles/volume] in Serum or Plasma 139 on 2026-07-13; Potassium [Moles/volume] in Serum or Plasma 4.4 on 2026-07-13; Creatinine [Mass/volume] in Serum or Plasma 0.98 on 2026-07-13; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 62 on 2026-07-13; Glucose [Mass/volume] in Serum or Plasma 93 on 2026-07-13; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 2026-03-09; Cholesterol [Mass/volume] in Serum or Plasma 160 on 2026-06-15; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 82 on 2026-06-15; Cholesterol in HDL [Mass/volume] in Serum or Plasma 56 on 2026-06-15; Triglyceride [Mass/volume] in Serum or Plasma 110 on 2026-06-15; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 2026-03-09; Albumin/Creatinine [Mass Ratio] in Urine 18 on 2026-03-09; Hemoglobin [Mass/volume] in Blood 12.8 on 2026-03-09; Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 on 2026-09-14; Total interval score [KOOSJR] 66.2 on 2026-09-14; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 on 2026-03-16; Left ventricular Ejection fraction 64 on 2026-04-13; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 2026-07-13; Total score [Mini-Cog] 5 on 2026-07-13; Total score [AUDIT-C] 1 on 2026-07-13 [S]

Strengths and supports: Strengths, supports and purpose: decades of nursing and healing, courage, humour, her writing and her friendships with old soldiers; she wants to keep walking to see her friends [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Headaches on waking for three weeks and blood pressure 184/102 mmHg at the visit (average of two seated readings with a large cuff); no chest pain, breathlessness, visual loss, confusion or weakness; fundi with arteriolar narrowing but no hemorrhages or papilledema; no hypertensive emergency; hypertension not yet confirmedresolvedprovisional R03.0S — Synthetic presenting problem; resolved into stage 2 hypertension when a week of home readings confirmed it. Not a claim about her real health.
Stage 2 hypertension confirmed by home readings (seven-day average 168/96 mmHg), with left ventricular hypertrophy by ECG voltage; no albuminuria; 10-year cardiovascular risk about 14%; treated to reduce the risk of stroke, heart failure and kidney diseaseactiveconfirmed I10S — Synthetic modern diagnosis made at the second visit. It is linked to the recorded apoplexy before her death only as the reason for the stroke-prevention teaching; the record does not claim that she had hypertension.
Bilateral primary knee osteoarthritis, worse on the left: pain on stairs and on rising from a chair, morning stiffness under 30 minutes, crepitus and bony enlargement without warmth; clinical diagnosis without imagingactiveconfirmed M17.0S — Synthetic modern problem; not a claim about her real health.
Fall risk: one fall in the past year, a trip on the outside steps without injury; afraid of falling and going out less; STEADI screen positive; Timed Up and Go 15 secondsactiveconfirmed Z91.81S — Synthetic fall-risk problem.
Obesity, class 1 (BMI 31.6); she calls herself stout and wants to lose some weight for her kneesactiveconfirmed E66.811S — Synthetic modern problem; her self-description as stout is documented, her weight is not.
Thiazide-associated hyponatremia (sodium 129 mmol/L) and hypokalemia (potassium 3.3 mmol/L) with orthostatic hypotension and a near-fall, after four days of a cold with little food while taking chlorthalidone; no confusion; resolved after chlorthalidone was stoppedresolvedconfirmed E87.1S — Synthetic adverse drug event at an unscheduled visit; a common effect of thiazide diuretics in older women, not a historical diagnosis.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-09Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-03-09Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2026-03-09Creatinine [Mass/volume] in Serum or Plasma0.92mg/dL0.59-1.04 mg/dLNormalS
2026-03-09Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M67mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-09Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
2026-03-09Hemoglobin A1c/Hemoglobin.total in Blood5.6%<=5.6%NormalS
2026-03-09Cholesterol [Mass/volume] in Serum or Plasma228mg/dL<=199 mg/dLHighS
2026-03-09Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation146mg/dL<=99 mg/dLHighS
2026-03-09Cholesterol in HDL [Mass/volume] in Serum or Plasma54mg/dL>=50 mg/dLNormalS
2026-03-09Triglyceride [Mass/volume] in Serum or Plasma140mg/dL<=149 mg/dLNormalS
2026-03-09Thyrotropin [Units/volume] in Serum or Plasma2.1m[IU]/L0.4-4 mIU/LNormalS
2026-03-09Albumin/Creatinine [Mass Ratio] in Urine18mg/g{creat}<=29 mg/g{creat}NormalS
2026-03-09Hemoglobin [Mass/volume] in Blood12.8g/dL11.6-15 g/dLNormalS
2026-03-09Pain severity - 0-10 verbal numeric rating [Score] - Reported6{score}S
2026-03-09Total interval score [KOOSJR]52.5{score}S
2026-03-16Pain severity - 0-10 verbal numeric rating [Score] - Reported6{score}S
2026-03-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-04-13Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
2026-04-13Potassium [Moles/volume] in Serum or Plasma3.7mmol/L3.5-5.1 mmol/LNormalS
2026-04-13Creatinine [Mass/volume] in Serum or Plasma0.95mg/dL0.59-1.04 mg/dLNormalS
2026-04-13Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M64mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-13Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-04-13Left ventricular Ejection fraction64%50-70%NormalS
2026-04-13Pain severity - 0-10 verbal numeric rating [Score] - Reported5{score}S
2026-04-13Total interval score [KOOSJR]56.6{score}S
2026-05-11Sodium [Moles/volume] in Serum or Plasma129mmol/L135-145 mmol/LLowS
2026-05-11Potassium [Moles/volume] in Serum or Plasma3.3mmol/L3.5-5.1 mmol/LLowS
2026-05-11Creatinine [Mass/volume] in Serum or Plasma1.05mg/dL0.59-1.04 mg/dLHighS
2026-05-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M57mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
2026-05-11Glucose [Mass/volume] in Serum or Plasma102mg/dL70-99 mg/dLHighS
2026-06-15Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-06-15Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-06-15Creatinine [Mass/volume] in Serum or Plasma0.94mg/dL0.59-1.04 mg/dLNormalS
2026-06-15Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M65mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-06-15Glucose [Mass/volume] in Serum or Plasma95mg/dL70-99 mg/dLNormalS
2026-06-15Cholesterol [Mass/volume] in Serum or Plasma160mg/dL<=199 mg/dLNormalS
2026-06-15Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation82mg/dL<=99 mg/dLNormalS
2026-06-15Cholesterol in HDL [Mass/volume] in Serum or Plasma56mg/dL>=50 mg/dLNormalS
2026-06-15Triglyceride [Mass/volume] in Serum or Plasma110mg/dL<=149 mg/dLNormalS
2026-06-15Pain severity - 0-10 verbal numeric rating [Score] - Reported4{score}S
2026-06-15Total interval score [KOOSJR]61.6{score}S
2026-07-13Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-07-13Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
2026-07-13Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.59-1.04 mg/dLNormalS
2026-07-13Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M62mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-07-13Glucose [Mass/volume] in Serum or Plasma93mg/dL70-99 mg/dLNormalS
2026-09-14Pain severity - 0-10 verbal numeric rating [Score] - Reported3{score}S
2026-09-14Total interval score [KOOSJR]66.2{score}S
2026-07-13Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-07-13Total score [Mini-Cog]5{score}S
2026-07-13Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-03-09Body height157cmS
2026-03-09Body weight78kgS
2026-03-09Body mass index (BMI) [Ratio]31.6kg/m2S
2026-03-09Systolic blood pressure184mm[Hg]S
2026-03-09Diastolic blood pressure102mm[Hg]S
2026-03-09Heart rate78/minS
2026-03-09Respiratory rate16/minS
2026-03-09Body temperature36.7CelS
2026-03-09Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-03-16Body height157cmS
2026-03-16Body weight78kgS
2026-03-16Body mass index (BMI) [Ratio]31.6kg/m2S
2026-03-16Systolic blood pressure176mm[Hg]S
2026-03-16Diastolic blood pressure98mm[Hg]S
2026-03-16Heart rate76/minS
2026-03-16Respiratory rate16/minS
2026-03-16Body temperature36.6CelS
2026-03-16Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-04-13Body height157cmS
2026-04-13Body weight77.6kgS
2026-04-13Body mass index (BMI) [Ratio]31.5kg/m2S
2026-04-13Systolic blood pressure138mm[Hg]S
2026-04-13Diastolic blood pressure82mm[Hg]S
2026-04-13Heart rate76/minS
2026-04-13Respiratory rate16/minS
2026-04-13Body temperature36.6CelS
2026-04-13Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-06-15Body height157cmS
2026-06-15Body weight77.2kgS
2026-06-15Body mass index (BMI) [Ratio]31.3kg/m2S
2026-06-15Systolic blood pressure144mm[Hg]S
2026-06-15Diastolic blood pressure84mm[Hg]S
2026-06-15Heart rate74/minS
2026-06-15Respiratory rate16/minS
2026-06-15Body temperature36.7CelS
2026-06-15Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-09-14Body height157cmS
2026-09-14Body weight76kgS
2026-09-14Body mass index (BMI) [Ratio]30.8kg/m2S
2026-09-14Systolic blood pressure128mm[Hg]S
2026-09-14Diastolic blood pressure76mm[Hg]S
2026-09-14Heart rate72/minS
2026-09-14Respiratory rate16/minS
2026-09-14Body temperature36.6CelS
2026-09-14Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-05-11Body height157cmS
2026-05-11Body weight77kgS
2026-05-11Body mass index (BMI) [Ratio]31.2kg/m2S
2026-05-11Systolic blood pressure118mm[Hg]S
2026-05-11Diastolic blood pressure70mm[Hg]S
2026-05-11Heart rate90/minS
2026-05-11Respiratory rate16/minS
2026-05-11Body temperature37.2CelS
2026-05-11Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-07-13Body height157cmS
2026-07-13Body weight76.8kgS
2026-07-13Body mass index (BMI) [Ratio]31.2kg/m2S
2026-07-13Systolic blood pressure132mm[Hg]S
2026-07-13Diastolic blood pressure78mm[Hg]S
2026-07-13Heart rate72/minS
2026-07-13Respiratory rate16/minS
2026-07-13Body temperature36.6CelS
2026-07-13Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-03-09Visit for headaches on waking and knee pain with a fall: very high blood pressure found, without target-organ emergency; examination, ECG, laboratory tests, home monitoring, knee osteoarthritis, falls screen, her own remedies, and geriatric medicine referralfinishedS
2026-03-16One-week review with geriatric medicine: home readings confirm stage 2 hypertension; two first-line medicines; comprehensive geriatric assessment of falls, function, mood and social needsfinishedS
2026-04-13Four-week review: blood pressure, sodium and potassium on chlorthalidone, echocardiogram, statin decision, knee exercise program and canefinishedS
2026-06-15Three-month review after chlorthalidone was stopped: blood pressure above target, losartan added; lipids on atorvastatin; knee and fallsfinishedS
2026-09-14Six-month review: blood pressure at target, screening and bone density results, knee function, falls and social connectionfinishedS
2026-05-11Same-day sick visit for dizziness on standing during a coldfinishedS
2026-07-13Subsequent annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Dignified, culturally safe care: address her as Mrs. Seacole; respect her expertise as a nurse and healer; ask about her remedies openly and check them for interactions without dismissing them; explain each choice plainly and let her decide; solve access barriers (a free home blood pressure cuff in a large size, transport, the stairs) rather than treat them as non-adherencecompletedGL-AHA-HTN-2025, GL-NCCIH-LICORICES
Geriatric medicine consultation within one week for a comprehensive geriatric assessment: falls, blood pressure targets and medicine choices in an older woman living alone, knee osteoarthritis, mood and social needscompletedGL-CDC-STEADI, GL-AHA-HTN-2025S
Confirm the blood pressure: home readings twice daily for seven days with a validated upper-arm monitor and a large cuff, technique taught; ECG, metabolic panel, lipids, hemoglobin A1c, TSH, urine albumin and blood count today; an echocardiogram for stage 2 readings with ECG voltage for left ventricular hypertrophy; treatment decided at the one-week reviewcompletedGL-AHA-HTN-2025, GL-CMID-2026S
Knee osteoarthritis: exercise therapy with a physical therapist, then a tai chi class at the community center; diclofenac 1% gel; a 5% weight loss; a cane, fitted and used in the right hand; no oral anti-inflammatory medicines because of her blood pressure and kidneys; a corticosteroid injection as an option for a flarecompletedGL-ACR-OA-2019, GL-CMID-2026S
Falls (STEADI): screen, then Timed Up and Go, 30-second chair stand, 4-stage balance test and orthostatic blood pressure at visits; medicine review against the Beers criteria; vision and footwear checks; a home safety visit by an occupational therapist, with a rail for the stairs to her rooms; exercise for strength and balancecompletedGL-CDC-STEADI, GL-USPSTF-FALLS-2024, GL-AGS-BEERS-2023S
Her own remedies, checked with her: liquorice root can raise blood pressure and lower potassium, so she will pause it while her blood pressure is treated (her decision); ginger tea in food amounts is fine; her camphor and wintergreen liniment contains a salicylate, so it is used on a different knee or at a different time from the diclofenac gel, never under a heat pad, and kept away from the eyescompletedGL-NCCIH-LICORICE, GL-NCCIH-GINGER, GL-ACR-OA-2019S
Loneliness and costs: a social prescribing link worker; the tai chi group and a lunch club near her home; a check of the help she is entitled to with costs and transport; generic medicines and a 90-day supplycompletedGL-AHA-HTN-2025S
Lifestyle: less salted fish and pickled food, more vegetables and fruit, regular walking, and alcohol kept to occasionscompletedGL-AHA-HTN-2025, GL-CMID-2026S
Two first-line medicines for stage 2 hypertension: amlodipine 5 mg and chlorthalidone 12.5 mg each morning, with sodium, potassium and creatinine in about four weeks and orthostatic readings at each visit; target below 130/80 mmHg; sick-day rule: stop chlorthalidone and call if she cannot eat or drink normally, or has vomiting or diarrheacompletedGL-AHA-HTN-2025, GL-CMID-2026, GL-AGS-BEERS-2023S
Atorvastatin 20 mg daily (moderate intensity) for a 10-year cardiovascular risk of about 14% with LDL 146 mg/dL; lipid panel in four to twelve weekscompletedGL-ACC-CHOL-2018, GL-AHA-HTN-2025, GL-CMID-2026S
Chlorthalidone stopped for hyponatremia and hypokalemia with orthostatic hypotension; eat normally with some salt for a few days; sodium recheck in one weekcompletedGL-AGS-BEERS-2023, GL-AHA-HTN-2025S
Losartan 25 mg daily added to amlodipine 5 mg, with potassium and creatinine in two to four weeks; blood tests drawn at home by the community nurse when a separate trip would be neededcompletedGL-AHA-HTN-2025, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Blood pressure below 130/80 mmHg at home and in the clinic, without dizziness on standing2026-09-14completed128/76 in the clinic and 126/74 at home on amlodipine and losartan, with no orthostatic dropS
Headaches gone2026-04-13completedNo headaches since the second week of treatmentS
Knee pain 3 or less out of 10 and walking 20 minutes a day with a cane2026-09-14completedPain 3 out of 10; KOOS JR 52.5 to 66.2; walks 20 minutes most daysS
Lose 5% of body weight (about 4 kg)2026-09-14active78.0 to 76.0 kg (2.6%)S
No falls2026-09-14activeNo falls in six months; one near-fall during the sodium problem, without injuryS

Functional Status

Mental Status